Workflow
Healthcare Services
icon
搜索文档
TailorCare Expands Value-Based Musculoskeletal Care for Humana Medicare Advantage Members in Dallas and Denver
Businesswire· 2025-09-23 22:30
NASHVILLE, Tenn.--(BUSINESS WIRE)--TailorCare, a leading provider of value-based specialty care solutions for musculoskeletal (MSK) health, today announced plans to expand its partnership with Humana Inc. (NYSE: HUM) into Dallas and Denver. Humana Medicare Advantage (MA) members who qualify for these programs will now have access to TailorCare's personalized, evidence-based MSK navigation and care coordination support. Currently serving Humana members in Atlanta, TailorCare advances quality of. ...
McKesson stock rises on improved adjusted EPS outlook (MCK:NYSE)
Seeking Alpha· 2025-09-23 20:43
McKesson (NYSE:MCK) announced on Tuesday an improvement to its fiscal 2026 adjusted EPS guidance range to $38.05-$38.55 from $37.10-$37.90, vs. $37.48 consensus. Shares were +1.72% pre-market to $709.00. The healthcare services company is set to host its 2025 Investor Day today, beginning ...
NextPlat's ClearMetrx Subsidiary to Launch Artificial Intelligence-Powered ClearMetrX 4.0 Software for Modernized Healthcare Analytics and Reporting
Prnewswire· 2025-09-23 20:01
Accessibility StatementSkip Navigation Highlighted features of ClearMetrX 4.0 include: solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to launch additional e-commerce capabilities ...
Ardent Announces Successful Amendment and Extension of Term Loan Facility
Businesswire· 2025-09-23 04:30
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it has successfully amended and extended its $777.5 million Term Loan Facility. The new terms reduce the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 2.75% to Term SOFR plus 2.25%. The transaction extends the maturity of the facility to September 2032. "This transaction e. ...
Ramaswamy-backed Strive to buy Semler in $1.3 billion deal all stock deal, boosting Bitcoin holdings
Yahoo Finance· 2025-09-22 22:21
(Reuters) -Strive said on Monday it will acquire Semler Scientific in an all-stock deal valued at about $1.34 billion, as the bitcoin-treasury company backed by former Republican U.S. presidential candidate Vivek Ramaswamy moves to expand its cryptocurrency holdings. Semler shareholders will receive 21.04 Class A common shares of Strive for each Semler share, valuing Semler at $90.52 per share, a premium of more than 210% to its Friday close. The deal comes less than five months after Strive announced a ...
Premier Set For Private Ownership, Eyes Growth Push
Yahoo Finance· 2025-09-22 21:11
收购交易核心条款 - 公司将以每股28.25美元的现金价格被Patient Square Capital的关联公司收购 [1] - 该交易价格较公司截至2025年9月5日的60日平均收盘价有23.8%的溢价 [1] - 交易预计将于2026年第一季度完成 需获得股东和监管机构批准 且不附带融资条件 [3] 公司管理层观点 - 董事会一致批准该协议 认为出售能为投资者提供即时且确定的价值 [1] - 转为私有制将改善财务灵活性 并加速在技术、产品开发和咨询服务方面的投资 [2] - 公司自2013年上市以来持续增长 供应链专业知识和科技产品得到加强 [2] 收购方观点与市场反应 - 收购方Patient Square Capital认为公司在供应链、数据和咨询解决方案方面是创新者 [3] - 收购方认为公司作为私人控股企业具有巨大的扩张潜力 [3] - 消息公布后 公司股价在周一盘前交易中上涨8.54%至27.95美元 [4] 股息政策变动 - 公司宣布将于2025年9月15日支付每股21美分的股息 [3] - 在此之后 公司将暂停派发股息 [3]
Experian Health's 3rd Annual State of Claims Survey Finds Denials Still on the Rise Amid Escalating Challenges
Businesswire· 2025-09-22 18:00
COSTA MESA, Calif.--(BUSINESS WIRE)--The Experian Health 2025 State of Claims survey reveals growing challenges affecting healthcare providers. ...
Optum Insight names new CEO
Yahoo Finance· 2025-09-22 16:59
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Name: Sandeep Dadlani Previous title: Executive vice president and chief digital and technology officer, UnitedHealth New title: CEO, Optum Insight Dadlani started as chief executive of Optum Insight last week, the executive announced in a LinkedIn post saying he’s “honored and privileged” to step into the role. Dadlani first joined UnitedHealth in 2022 as the ...
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health
Globenewswire· 2025-09-21 20:35
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GLOBE NEWSW ...
CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount
ZACKS· 2025-09-19 21:51
CVS Health核心运营情况 - Oak Street Health在2025年初出现医疗成本趋势压力 第二季度医疗福利比率MBR上升 主要由于持续高企的医疗成本、会员结构变化以及更丰富的福利和补充福利 offerings [1] - Oak Street Health的风险会员总数同比增长31% [2] - 由于MBR上升 CVS将健康服务板块全年调整后运营收入指引下调约2亿美元 目前预期至少73.4亿美元 [2] - Signify Health业绩表现强劲 居家评估量持续强劲 部分抵消了医疗保健服务业务的压力 [1][10] CVS Health战略与管理措施 - 基于价值的护理是公司Medicare Advantage战略的核心组成部分 旨在提升临床结果、改善患者体验并降低总体护理成本 [3] - 公司已组建强大的领导团队 引入在基于价值的护理和人群健康管理方面经验丰富的新成员 [4] - 公司正在评估其技术栈和运营 以从技术角度提供领先的临床解决方案 目标是推动更好的医疗成本管理 [4] - 公司计划对Oak Street中心扩张采取审慎态度 优先考虑现有中心内的患者增长 [4][10] 竞争对手动态 - The Cigna Group子公司Evernorth Health Services宣布以优先股形式向专业药房管理公司Shields Health Solutions投资35亿美元 此项投资预计不会对Cigna此前发布的2025年调整后每股收益指引至少29.60美元产生重大影响 [5] - Elevance Health宣布与Vori Health和HOPCo建立新的战略性个体化基于价值的护理合作伙伴关系 并扩大与TailorCare的现有合作 以提升肌肉骨骼疾病护理质量并优化患者健康结果 [6] 股票表现与估值 - 过去一年 CVS Health股价上涨29.4% 而同期行业指数下跌18.8% [9] - CVS Health的远期12个月市销率P/S为0.23倍 低于0.39倍的行业平均水平 价值评分为A [11] - 公司当前Zacks评级为3级持有 [13] 分析师盈利预测趋势 - 2025年第三季度9月每股收益预测为1.36美元 与7天前持平 但低于90天前的1.42美元 [13] - 2025年第四季度12月每股收益预测为0.95美元 与7天前持平 但低于90天前的1.01美元 [13] - 2025年全年12月每股收益预测为6.34美元 与7天前持平 但高于60天前的6.12美元和90天前的6.10美元 [13] - 2026年全年12月每股收益预测为7.13美元 与7天前持平 但高于90天前的6.97美元 [13]